Combinatory effects of gemcitabine and inhibitors targeting PI3K-Akt-mTOR pathway in human pancreatic and breast cancer cells.

a<p>The values represent the average of three independent experiments.</p>b<p>IC50 values between combination treatment vs. Gem along were analyzed statistically by performing t tests.</p><p>Abbreviations: Gem, gemcitabine; TCN, tricirbine; Rap, rapamycin.</p>